Fresh Target in Hunt for a Migraine Cure - WSJ.

com

9/6/12 12:29 PM

News, Quotes, Companies, Videos

SEARCH

Richard Golden

My Journal

Messages (0)

U.S. EDITION

Tuesday, August 7, 2012 As of 11:33 AM EDT

Home

World

U.S.

New York
Cars

Business

Tech

Markets
Food & Drink

Market Data
Sports Travel

Opinion
Health

Life & Culture

Retirement Planning

Real Estate
WSJ. Magazine

Careers
Off Duty
3 of 8

Arts & Entertainment

Books & Ideas

Fashion
1 of 8

The A-Hed

2 of 8

TOP STORIES IN

Health & Wellness

IN THE LAB

'Junk DNA' Debunked

This Isn't Candid Camera, It's a Science Project

L.A. Pot Ban Is Blocked for Now

NFL Fu Injury S

Updated August 7, 2012, 11:33 a.m. ET

Fresh Target in Hunt for a Migraine Cure

Article
Video Comments (50)

By SHIRLEY S. WANG

MORE IN HEALTH & WELLNESS

Email

Print

Don't Miss!

Powered by Taboola

Illustration by Bernard Maisner

The hunt is intensifying for new treatments for migraines, the common and debilitating headaches that have confounded scientists for decades. Of greatest focus for researchers is a brain chemical known as CGRP, which appears to play a role in the transmission of pain, but not in other brain functions, such as cognition or mood. Researchers are trying a variety of experimental drugs to stop CGRP from working by blocking its receptors in the brain. Others are working on artificial antibodies that could soak up the chemical in the bloodstream or brain before it can trigger migraines. Experts say the need for new medicines to treat migraine pain once it begins is great because current drugs only provide some benefit for 50% to 60% of sufferers and

Fresh Target in Hunt for a Migraine Cure 03:51

Fluke: Do You Want a President That Has Our Back, or Turns His Back? 06:35

Opinion Journal: The Clinton Comeback -- Monica Crowley p 05:25

Recent Columns
Tricks From Elderly to Stop Worrying What Eyes Reveal About Your Health Fresh Target in Hunt for Migraine Cure

About In The Lab

In the Lab explores cutting-edge research that holds the promise of answers some of medicine biggest and smallest questions. Every

http://online.wsj.com/article/SB10000872396390444320704577567352444742524.html?KEYWORDS=headache

Page 1 of 5

Fresh Target in Hunt for a Migraine Cure - WSJ.com

9/6/12 12:29 PM

can't be used in people with heart disease or who have had a stroke. Also, they aren't a cure, and in many cases, the
The hunt is intensifying for new treatments for migraines, the common and debilitating headaches that have confounded scientists for decades. WSJ's Shirley Wang reports on the latest approaches. Photo: Getty Images

other Tuesday, Shirley Wang, a former researcher who has published work in peer-reviewed journals, takes you into the labs of scientists from around the world to understand why the body is the way it is and what advances are to come in health and medicine.

headaches tend to come back within 24 hours.

More in Health & Wellness

My Muscle Mentor The Risk of Catching Something When Workouts Turn Obsessive Study: Calorie Cuts Don't Equal Longer Life Going to the Mat to Fight Skin Infections

There also is a separate category of preventive drugs, which tend to be used by a small proportion of people who suffer from more frequent or debilitating migraines. "People need migraine drugs that have a rapid onset of action, that take the pain away and keep it away," says Richard Lipton, director of the Montefiore Headache Center in New York. Headache disorders are among the most common medical conditions world-wide. More than 1 in 10 adults globally are affected by migraines, which can be incapacitating, according to the World Health Organization. International studies have found that 50% to 75% of adults have reported a headache in the past year, with up to 4% of the global population reporting having a headache in half or more of the days each month, WHO says.

Most Popular
Read Emailed Video Commented

1. 2. 3. 4. 5.

Nokia, Motorola Race to Beat Apple

After Stainless, Now What? Motorola Debuts Three Phones Under Google's Umbrella Jerusalem Language Restored by Democrats Clinton Makes Case for Obama

Enlarge Image

Most Read Articles Feed

There isn't such a thing as a "regular" headache, but rather more than 300 types, says David Dodick, a professor of neurology at the Mayo Clinic's branch in Phoenix and chairman of the American Migraine Foundation. People having migraines usually experience intense pain, sensitivity to light, dizziness and sometimes nausea and visual and sensory symptoms called auras. Two other major types of headaches are caused by tension or medication overuse. More on the Aching Heads
Beware, a Big Headache Is Coming: Spotting Often-Overlooked Clues Doctors' Challenge: How Real Is That Pain? Breaking the Headache Cycle HEALTH BLOG: Readers Weigh in With Their Own Migraine Remedies

Latest Headlines
L.A. Pot Ban Is Blocked for Now Democrats Hint at Showdown With GOP After Election Hovnanian's Revenue Surges Positive Signs Emerge for Job Market Report Cites Health-Care Waste Former Ravens Owner Art Modell Dies Group Reopens CIA Torture Allegations Rare Gold Coins Belong to Mint, Judge Decides Little Progress in U.S.-China Talks Guilty Pleas in Ohio Bridge-Bomb Plot
More Headlines

Nonsteroidal anti-inflammatory painkillers such as ibuprofen work for some migraine sufferers. But the class of migraine medicines that hit the market in the 1990s called triptans remain the best or only treatment option for many patients. Nevertheless, about half of sufferers don't respond to them or can't take them

because of other health reasons. CGRP, which stands for calcitonin gene-related peptide neurotransmitter, has long been thought to play a role in migraines, but for much of that time for the wrong reason. Part of the confusion was because of a misunderstanding of migraines themselves. Why they occur still isn't clear, but specialists say they have recently begun to understand the migraine as a brain disorder and not a vascular disorder. Until about 12 years ago, they were believed to stem from constriction of blood vessels in the brain. The dilation of the vessels to compensate then led to the throbbing pain, so the thinking went. Now, it appears more likely that migraines "hijack" the brain's normal pain circuitry, says Dr. Dodick. The brain's normal pain-sensory system, in which nerve endings send messages to the brain about a threat, goes awry in migraines. Experts disagree about how a migraine is triggered, but the trigeminal nervean important pathway that carries sensory information about the faceand its connections

Relieve Migraine Pain Quickly Relieve The Pain Of A Migraine. See Top Recommended Products. chamomax.com Lynnwood Chiropractor Chiropractic & Massage for Neck and Back pain, Headaches, Auto Injuries www.woodwaychiro.com Fibro Symptoms Pain Fibromyalgia Pain Symptoms, Treatments & Relief. Check Options Now. arthritistq.com

http://online.wsj.com/article/SB10000872396390444320704577567352444742524.html?KEYWORDS=headache

Page 2 of 5

Fresh Target in Hunt for a Migraine Cure - WSJ.com

9/6/12 12:29 PM

to numerous other nerves and the brain appear to be responsible for transmitting the pain. Researchers also have isolated certain genes that might be linked to a predisposition for migraines, Dr. Dodick says. Triptans, which promote blood-vessel constriction and inflammation, block the release of CGRP in the trigeminal nerve. While CGRP does aid the blood-vessel dilation process, its role activating the nerves in the brain appears to be the key when it comes to migraine pain. In the mid-1980s, Peter Goadsby, a neurologist and headache specialist at the University of California San Francisco, and his colleagues found that CGRP is released in migraines and that triptans decreased CGRP action. Several researchers and companies have been trying to develop drugs that bind to the CGRP receptors to prevent the chemical from activating the pain network. But because CGRP has a complex receptorthe slot where the molecule must bind in order to initiate actions in the bodyit took chemists 15 years to figure out how to block the effects of CGRP, and even longer to develop a compound that could be taken orally, says Dr. Goadsby. Bringing to market CGRP blockers, or antagoniststhe most advanced of the new drugs in development for migraineshas proved challenging. Several investigational compounds have been shown to be toxic to the liver, a challenge that highlights the difficulty in developing drugs for conditions that affect the brain. CGRP antagonists don't appear to work as well as triptans, but the blockers have an advantage in they don't appear to cause cardiovascular complications, says Stephen Silberstein, a neurology professor and director of Thomas Jefferson University's Headache Center in Philadelphia. "You trade one kind of risk for another," says Dr. Silberstein, who has served as an investigator on several companies' clinical trials. Merck & Co. had a promising CGRP-receptor antagonist under development but discovered in late-stage clinical-trial testing that some patients experienced liver enzyme changes. In July of last year, the company said it was discontinuing development of the compound, telcagepant, after looking at all its trial data. Germany's Boehringer Ingelheim GmbH was also working on a CGRP antagonist but canceled development. A spokesman declined to comment. Bristol-Myers Squibb Co. is conducting several early stage studies on CGRP antagonists and other companies are testing or may begin development of similar compounds as well. Researchers and companies also are trying to develop artificial antibodies that, when injected, would glom onto CGRP in the bloodstream or brain, before it reaches the receptors in the brain, or by blocking the receptors. Research into these biologic antibody-based approaches is at an earlier stage than the testing of antagonist drugs, but antibodies eventually might be able to block CGRP action regularly so that migraines don't ever begin. "The CGRP story is a story of developing an acute treatment for migraine," says Dr. Goadsby. "But the antibody story is testing the larger idea [that] if you blocked continuously CGRP, would you have a preventive treatment." Write to Shirley S. Wang at shirley.wang@wsj.com
A version of this article appeared August 7, 2012, on page D1 in the U.S. edition of The Wall Street

http://online.wsj.com/article/SB10000872396390444320704577567352444742524.html?KEYWORDS=headache

Page 3 of 5

Fresh Target in Hunt for a Migraine Cure - WSJ.com

9/6/12 12:29 PM

Journal, with the headline: Fresh Target in Hunt for a Migraine Cure.
JOIN THE DISCUSSION MORE IN

50 Comments, add yours

Health & Wellness

Email

Print

Order Reprints

QUAN Hot Stock Pick Volume Quadruples in One Day, Don't Miss Out - Buy Now! www.QuantumInnovators.com End Migraines - Tuliv MD End your suffering with Tuliv MD for the prevention of migraines. www.Tuliv.com See Todays Mortgage Rates Mortgages Plunge to 2.5% (2.9% APR). Research Your Options Now! www.SeeRefinanceRates.com Suffer With Migraines? Learn the Main Causes of Migraines & Chronic Headaches, Find Relief! balancedspine.com

You Might Like

Ex-Jet Chrebet Among Top Wealth Managers Leaving Morgan Stanley for Barclays Todd Akin Is Not a Victim IKEA Discloses an $11 Billion Secret Misdiagnosed: When It Isnt Alzheimers Russias Putin, Friend of Fauna, Flies Into Another Stunt

From Around the Web

Content from Sponsors What's this?

Silent Heart Attacks Threaten Americans Over Age 40 (Newsmax.com) How many gallons of gasoline would it take to charge an iPhone? (ExxonMobil's Perspectives) Smoking Update: 12 More Reasons To Quit
(Lifescript.com)

British Gold Medalist Jessica Ennis Hot Body Pictures (Zimbio) Expert: Gas Could Soon Be Unaffordable For Average Americans (Money Morning)

Add a Comment
View All Comments (50)

JOURNAL COMMUNITY

Community rules

All comments will display your real name. Start typing your comments here...

Track replies to my comment CLEAR POST Login with Facebook

Editors' Picks

Putin Shows Softer Side in Latest Photo Op

Warhol Art Trove Pops Up for Sale

Egyptian Bets on Natural Gas in Iowa

Facebook May Have Known Risks, Wasn't Persuaded

As The Office Ends, Ricky Gervais Spills Secrets From the Shows Start

http://online.wsj.com/article/SB10000872396390444320704577567352444742524.html?KEYWORDS=headache

Page 4 of 5

Fresh Target in Hunt for a Migraine Cure - WSJ.com

9/6/12 12:29 PM

Wall Street Facebook Journal Twitter LinkedInFourSquare Google+ YouTube Podcasts RSS Feed

AppStore

Back to Top

Customer Service
Customer Center Asia/Europe Support Contact Us Corrections

Policy
Privacy Policy Data Policy Copyright Policy Subscriber Agreement & Terms of Use

Ads
Your Ad Choices Advertise Advertise Locally Place a Classified Ad

Tools & Features

Apps Newsletters Alerts Graphics Columns Topics Guides

More
Register for Free Reprints E-books Content Partnerships Conferences SafeHouse

Help

Contact Directory

Jobs at WSJ

Copyright 2012 Dow Jones & Company, Inc. All Rights Reserved.

http://online.wsj.com/article/SB10000872396390444320704577567352444742524.html?KEYWORDS=headache

Page 5 of 5